Mark R Woodford

Dr. Mark R Woodford

SUNY Upstate Medical University, Syracuse, Indiana, USA
orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in Molecular Cell
Verified
Journal Article
Closed access
MMMehdi Mollapour
Mehdi Mollapour
DBDimitra Bourboulia
Dimitra Bourboulia
KBKristin Beebe
Kristin Beebe
MWMark R Woodford
Mark R Woodford
SPSigrun Polier
Sigrun Polier
LNLen Neckers
Len Neckers

10 November 2017 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MWMark R Woodford
Mark R Woodford
RSRebecca A Sager
Rebecca A Sager
EMElijah Marris
Elijah Marris
DDDiana M Dunn
Diana M Dunn
ABAdam R Blanden
Adam R Blanden
MMMehdi Mollapour
Mehdi Mollapour
The tumor suppressors Tsc1 and Tsc2 form the tuberous sclerosis complex (TSC), a regulator of mTOR activity. Tsc1 stabilizes Tsc2; however, the precise mechanism involved remains elusive. The molecular chaperone heat‐shock protein 90 (Hsp90) is an essential component of the cellular homeostatic machinery in eukaryotes. Here, we show that Tsc1 is a new co‐chaperone for Hsp90 that inhibits its ATPase activity. The C‐terminal domain of Tsc1 (998–1,164 aa) forms a homodimer and binds to both protomers of the Hsp90 middle domain. This ensures inhibition of both subunits of the Hsp90 dimer and prevents the activating co‐chaperone Aha1 from binding the middle domain of Hsp90. Conversely, phosphorylation of Aha1‐Y223 increases its affinity for Hsp90 and displaces Tsc1, thereby providing a mechanism for equilibrium between binding of these two co‐chaperones to Hsp90. Our findings establish an active role for Tsc1 as a facilitator of Hsp90‐mediated folding of kinase and non‐kinase clients—including Tsc2—thereby preventing their ubiquitination and proteasomal degradation.

27 July 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
JOJasmeen Oberoi
Jasmeen Oberoi
DDDiana M. Dunn
Diana M. Dunn
MWMark R Woodford
Mark R Woodford
LMLaura Mariotti
Laura Mariotti
JSJacqualyn Schulman
Jacqualyn Schulman
CVCara K. Vaughan
Cara K. Vaughan
Significance: The activity of many proteins is dependent on molecular chaperones and their accessory proteins, cochaperones. The ability of a cohort of kinases, many of which are oncogenic, to transduce signals is promoted by the heat shock protein 90 (Hsp90) chaperone and Cdc37 cochaperone, and requires the removal of a phosphate from Cdc37 by protein phosphatase 5 (PP5). We present the crystal structure of PP5 with Cdc37 trapped in the active site. The structure reveals how PP5 can associate with different substrates and previously unknown determinants of specificity. Our findings show kinase release from the chaperone complex is critically dependent on this dephosphorylation and that combined inhibition of both Hsp90 and PP5 could provide an effective therapeutic strategy for treating cancers addicted to these kinases.

1 February 2016 in Cell Reports
Verified
Journal Article
Open access
MWMark R Woodford
Mark R Woodford
ATAndrew Truman
Andrew Truman
DDDiana M. Dunn
Diana M. Dunn
SJSandra M. Jensen
Sandra M. Jensen
RCRichard Cotran
Richard Cotran
MMMehdi Mollapour
Mehdi Mollapour
The molecular chaperone Hsp90 protects deregulated signaling proteins that are vital for tumor growth and survival. Tumors generally display sensitivity and selectivity toward Hsp90 inhibitors; however, the molecular mechanism underlying this phenotype remains undefined. We report that the mitotic checkpoint kinase Mps1 phosphorylates a conserved threonine residue in the amino-domain of Hsp90. This, in turn, regulates chaperone function by reducing Hsp90 ATPase activity while fostering Hsp90 association with kinase clients, including Mps1. Phosphorylation of Hsp90 is also essential for the mitotic checkpoint because it confers Mps1 stability and activity. We identified Cdc14 as the phosphatase that dephosphorylates Hsp90 and disrupts its interaction with Mps1. This causes Mps1 degradation, thus providing a mechanism for its inactivation. Finally, Hsp90 phosphorylation sensitizes cells to its inhibitors, and elevated Mps1 levels confer renal cell carcinoma selectivity to Hsp90 drugs. Mps1 expression level can potentially serve as a predictive indicator of tumor response to Hsp90 inhibitors.

29 June 2016 in Nature Communications
Verified
Journal Article
Open access
MWMark R Woodford
Mark R Woodford
DDDiana M. Dunn
Diana M. Dunn
ABAdam R. Blanden
Adam R. Blanden
DCDante Capriotti
Dante Capriotti
DLDavid Loiselle
David Loiselle
MMMehdi Mollapour
Mehdi Mollapour
Heat shock protein-90 (Hsp90) is an essential molecular chaperone in eukaryotes involved in maintaining the stability and activity of numerous signalling proteins, also known as clients. Hsp90 ATPase activity is essential for its chaperone function and it is regulated by co-chaperones. Here we show that the tumour suppressor FLCN is an Hsp90 client protein and its binding partners FNIP1/FNIP2 function as co-chaperones. FNIPs decelerate the chaperone cycle, facilitating FLCN interaction with Hsp90, consequently ensuring FLCN stability. FNIPs compete with the activating co-chaperone Aha1 for binding to Hsp90, thereby providing a reciprocal regulatory mechanism for chaperoning of client proteins. Lastly, downregulation of FNIPs desensitizes cancer cells to Hsp90 inhibitors, whereas FNIPs overexpression in renal tumours compared with adjacent normal tissues correlates with enhanced binding of Hsp90 to its inhibitors. Our findings suggest that FNIPs expression can potentially serve as a predictive indicator of tumour response to Hsp90 inhibitors.

1 August 2019 in Cell Reports
Verified
Journal Article
Open access
ABAlexander J. Baker-Williams
Alexander J. Baker-Williams
FHFiza Hashmi
Fiza Hashmi
MBMarek A. Budzyński
Marek A. Budzyński
MWMark R Woodford
Mark R Woodford
SGStephanie Gleicher
Stephanie Gleicher
DBDIMITRA BOURBOULIA
DIMITRA BOURBOULIA
The extracellular molecular chaperone heat shock protein 90 (eHSP90) stabilizes protease client the matrix metalloproteinase 2 (MMP2), leading to tumor cell invasion. Although co-chaperones are critical modulators of intracellular HSP90:client function, how the eHSP90:MMP2 complex is regulated remains speculative. Here, we report that the tissue inhibitor of metalloproteinases-2 (TIMP2) is a stress-inducible extracellular co-chaperone that binds to eHSP90, increases eHSP90 binding to ATP, and inhibits its ATPase activity. In addition to disrupting the eHSP90:MMP2 complex and terminally inactivating MMP2, TIMP2 loads the client to eHSP90, keeping the protease in a transient inhibitory state. Secreted activating co-chaperone AHA1 displaces TIMP2 from the complex, providing a "reactivating" mechanism for MMP2. Gene knockout or blocking antibodies targeting TIMP2 and AHA1 released by HT1080 cancer cells modify their gelatinolytic activity. Our data suggest that TIMP2 and AHA1 co-chaperones function as a molecular switch that determines the inhibition and reactivation of the eHSP90 client protein MMP2.